Custom Search

Infectious Disease Online

Pathology of Trachoma

Dr Sampurna Roy MD

 

Trachoma is a chronic progressive infection of the conjunctiva and cornea that may cause partial or total blindness.

Infection with Chlamydia trachomatis, subgroups A, B, Ba, and C is the leading cause of preventable blindness in the world.

The blinding complications are associated with progressive conjunctival scarring.

The disease is worldwide, associated with poverty, and most prevalent in dry or sandy regions.

Only humans are naturally infected. Poor personal hygiene and inadequate public sanitation are common factors.

Mode of infection:  

Spread mostly by direct contact, trachoma is also transmitted by fomites, contaminated water, cosmetics, and probably flies.

Subclinical infections are an important reservoir.

Clinical presentation:  

In endemic areas infection is acquired early in childhood, becomes chronic, and eventually progresses to blindness.

An abrupt onset of palpebral and conjunctiva inflammation leads to lacrimation, purulent conjunctivitis, and photophobias.

As chronic inflammation progresses over months and years there is scarring of the upper tarsal plate and corneal keratitis, with formation of a vascular pannus. 

Scarring, trichiasis and entropian eventually interfere with normal ocular function. Secondary bacterial infections and corneal ulceration are common.

Morphological features:

In a study of specimens taken from patients with active trachoma the histology showed inflammatory infiltrate organized as lymphoid follicles in the underlying stroma.

The impression cytology showed cytoplasmic elementary bodies.

In specimens taken from patients with scarring trachoma light microscopic studies showed subepithelial fibrous membrane formation, squamous metaplasia and loss of goblet cells, pseudogland formation in conjunctiva, degeneration of orbicularis oculi muscle fibres, subepithelial vascular dilatation, localized perivascular amyloidosis and subepithelial lymphocytic infiltration.

Accessory lachrymal glands and the ducts of glands showed subepithelial infiltration and scarring.

Note:

In trachoma the cornea is eventually invaded by blood vessels and fibroblasts to form the trachomatous pannus.

Necrosis eventually occurs, specially in the lymphoid follicles, causing extensive conjunctival scarring.

Resorption of lymphoid follicles at the limbus results in indentations called Herbert's pits.

On microscopic examination the desquamated conjunctival epithelium exhibits glycogen-rich intracytoplasmic inclusion bodies and large macrophages containing nuclear fragments (Leber cells).

 

Diagnosis of Trachoma:

Diagnosis of trachoma is based on the clinical findings and the demonstration of organisms in smears or cultures.

Scrapings of the superficial conjunctiva stained with Giemsa or by direct immunofluorescence may reveal diagnostic intracytoplasmic inclusions.

Treatment:

Trachoma responds to topical and systemic tetracycline, but endemic trachoma is difficult to treat because of repeated exposure. All members of a family or social group should be treated to prevent retransmission.

Vaccines have been ineffective, and those administered systemically tend to exacerbate the disease.

Improved hygiene and public sanitation are the most effective control measures.

 

Further reading:

The global burden of trachoma: a review.

Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines.

Correlation of clinical trachoma and infection in Aboriginal communities.

Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.

Prevalence and distribution of active trachoma in children of less than five years of age in trachoma endemic regions of Oman in 2005.

The frequency of Chlamydia trachomatis major outer membrane protein-specific CD8+ T lymphocytes in active trachoma is associated with current ocular infection.

Trachoma is still a pediatric disease.

Oculogenital Chlamydia trachomatis infections in adults.

                                                                                                                      

 

 

Visit:-  Dermatopathology Online

 

Dr Sampurna Roy  MD

Consultant  Histopathologist (Kolkata - India)

 


Copyright © 2022  histopathology-india.net